Preferred Name |
lexatumumab |
Synonyms |
HGS-ETR2 |
ID |
http://purl.bioontology.org/ontology/MESH/C510234 |
altLabel |
HGS-ETR2 ETR2-ST01 HGS1018 HGS-1018 |
cui |
C1721684 C5201264 C1721685 C5227802 |
HM |
D000911 |
II |
D053220 |
Inverse of RB |
967Q0SJD77 |
isa | |
Mapped to | |
MDA |
20060515 |
MeSH Frequency |
48 |
MMR |
20191031 |
notation |
C510234 |
PA |
D007155 |
prefLabel |
lexatumumab |
SC |
1 |
Scope Statement |
an disulfide-linked immunoglobulin G1, immunoglobulin lamda dimer with specificity for the human tumor necrosis factor receptor superfamily, member 10b |
TERMUI |
T673878 T000966283 T673877 T000966281 T000966282 |
TH |
NLM (2006) FDA SRS (2017) USAN (2006) INN (19XX) NLM (2020) |
tui |
T116 T129 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64621 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |